Joseph P. Hagan
2020 - Regulus Therapeutics
In 2020, Joseph P. Hagan earned a total compensation of $2.3M as President & Chief Executive Officer at Regulus Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $264,720 |
|---|---|
| Option Awards | $1,507,054 |
| Salary | $551,500 |
| Other | $9,860 |
| Total | $2,333,134 |
Hagan received $1.5M in option awards, accounting for 65% of the total pay in 2020.
Hagan also received $264.7K in non-equity incentive plan, $551.5K in salary and $9.9K in other compensation.
Rankings
In 2020, Joseph P. Hagan's compensation ranked 4,853rd out of 13,090 executives tracked by ExecPay. In other words, Hagan earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,853 out of 13,090 | 63rd |
Division Manufacturing | 1,971 out of 5,621 | 65th |
Major group Chemicals And Allied Products | 778 out of 2,254 | 66th |
Industry group Drugs | 670 out of 1,954 | 66th |
Industry Pharmaceutical Preparations | 507 out of 1,459 | 65th |
Source: SEC filing on April 30, 2021.
Hagan's colleagues
We found two more compensation records of executives who worked with Joseph P. Hagan at Regulus Therapeutics in 2020.
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019